TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Gram Medicin AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
6,245
|
8,024
|
9,226 |
| Financial expenses |
1,084
|
0
|
221 |
| Earnings before taxes |
10,245
|
12,456
|
8,918 |
| EBITDA |
4,739
|
7,043
|
7,758 |
| Total assets |
79,940
|
52,157
|
38,311 |
| Current assets |
50,807
|
41,420
|
32,439 |
| Current liabilities |
21,154
|
3,047
|
2,687 |
| Equity capital |
56,164
|
46,642
|
33,520 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
70.3%
|
89.4%
|
87.5% |
| Turnover per employee |
6,245
|
8,024
|
9,226 |
| Profit as a percentage of turnover |
164.1%
|
155.2%
|
96.7% |
| Return on assets (ROA) |
14.2%
|
23.9%
|
23.9% |
| Current ratio |
240.2%
|
1359.4%
|
1207.3% |
| Return on equity (ROE) |
18.2%
|
26.7%
|
26.6% |
| Change turnover |
-1,924
|
-1,857
|
2,213 |
| Change turnover % |
-24%
|
-19%
|
32% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.